Tokyo
Japan
2
2021-03-18
2
2022-04-26
These are the the leading inventors for applications assigned to TAK-CIRCULATOR CO, LTD:
TAK-CIRCULATOR CO, LTD based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Nucleic acid inhibiting expression of the MEX3B gene, MEX3B gene expression inhibitor, method for inhibiting MEX3B gene expression, and prophylactic or therapeutic agent for disease caused by MEX3B gene expression
#2 | 2020-10-15 ✅ Patent 11,279,935 granted on 2022-03-22Method for screening prophylactic or therapeutic agents for diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, TNF, G-CSF, CXCL1, CXCL2, or CXCL5
Also check out TAK-CIRCULATOR CO., LTD's (Tokyo, Japan) applicant profile with 3 patent applications submitted.
374777 ⎘